What Researchers Did
Researchers performed a multicenter retrospective comparative cohort study to evaluate the efficacy of hyperbaric oxygen therapy (HBOT) in treating digital frostbite by comparing amputation outcomes between HBOT-treated and non-HBOT-treated groups.
What They Found
The study found a low overall amputation rate of 5.2% across both cohorts. There was no statistical difference in amputation characteristics between patients treated with HBOT and those without. However, patients receiving HBOT had a significantly longer hospital stay (22.2 days) compared to the non-HBOT group (6.39 days).
What This Means for Canadian Patients
Canadian patients with digital frostbite may not benefit from hyperbaric oxygen therapy (HBOT) in terms of preventing amputation. Furthermore, receiving HBOT could lead to a significantly longer hospital stay without improving amputation outcomes.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
As a retrospective study, this research is subject to inherent limitations such as potential selection bias and confounding factors.